ATE498622T1 - Prolinamidtetrazolderivate als nk3- rezeptorantagonisten - Google Patents

Prolinamidtetrazolderivate als nk3- rezeptorantagonisten

Info

Publication number
ATE498622T1
ATE498622T1 AT08760179T AT08760179T ATE498622T1 AT E498622 T1 ATE498622 T1 AT E498622T1 AT 08760179 T AT08760179 T AT 08760179T AT 08760179 T AT08760179 T AT 08760179T AT E498622 T1 ATE498622 T1 AT E498622T1
Authority
AT
Austria
Prior art keywords
receptor antagonists
prolinamide
tetrazole derivatives
disorders
adhd
Prior art date
Application number
AT08760179T
Other languages
English (en)
Inventor
Bo Han
Henner Knust
Matthias Nettekoven
Hasane Ratni
Xihan Wu
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE498622T1 publication Critical patent/ATE498622T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT08760179T 2007-06-07 2008-05-29 Prolinamidtetrazolderivate als nk3- rezeptorantagonisten ATE498622T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07109783 2007-06-07
PCT/EP2008/056587 WO2008148688A1 (en) 2007-06-07 2008-05-29 Prolinamide-tetrazole derivatives as nk3 receptor antagonists

Publications (1)

Publication Number Publication Date
ATE498622T1 true ATE498622T1 (de) 2011-03-15

Family

ID=39768738

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08760179T ATE498622T1 (de) 2007-06-07 2008-05-29 Prolinamidtetrazolderivate als nk3- rezeptorantagonisten

Country Status (14)

Country Link
US (1) US7501422B2 (de)
EP (1) EP2155729B1 (de)
JP (1) JP2010529068A (de)
KR (1) KR101163294B1 (de)
CN (1) CN101679385A (de)
AT (1) ATE498622T1 (de)
AU (1) AU2008258664B2 (de)
BR (1) BRPI0812253A2 (de)
CA (1) CA2690292A1 (de)
DE (1) DE602008005014D1 (de)
ES (1) ES2359598T3 (de)
IL (1) IL202282A0 (de)
MX (1) MX2009013116A (de)
WO (1) WO2008148688A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023042914A1 (en) * 2021-09-17 2023-03-23 Otsuka Pharmaceutical Co., Ltd. Pyrrolidine compounds as histone deacetylase inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040034019A1 (en) 2002-08-08 2004-02-19 Ronald Tomlinson Piperazine and piperidine derivatives

Also Published As

Publication number Publication date
CA2690292A1 (en) 2008-12-11
US20080306089A1 (en) 2008-12-11
KR101163294B1 (ko) 2012-07-05
EP2155729A1 (de) 2010-02-24
EP2155729B1 (de) 2011-02-16
MX2009013116A (es) 2010-01-15
JP2010529068A (ja) 2010-08-26
AU2008258664A8 (en) 2010-01-14
ES2359598T3 (es) 2011-05-25
BRPI0812253A2 (pt) 2014-12-23
DE602008005014D1 (de) 2011-03-31
IL202282A0 (en) 2010-06-16
WO2008148688A1 (en) 2008-12-11
CN101679385A (zh) 2010-03-24
AU2008258664B2 (en) 2012-07-05
US7501422B2 (en) 2009-03-10
AU2008258664A1 (en) 2008-12-11
KR20100020026A (ko) 2010-02-19

Similar Documents

Publication Publication Date Title
IL202236A0 (en) Prolinamide derivatives as nk3 antagonists
PH12013500247A1 (en) Heterocyclic compound and use thereof
MA32898B1 (fr) Modulateurs allosteriques positifs du recepteur m1 d'arylmethylbenzoquinazolinone
BRPI0410711A (pt) novos compostos
EA200901373A1 (ru) Аминогетероциклические соединения
ATE438632T1 (de) Aryl-4-ethinylisoxazolderivate
IL186777A0 (en) (3,4-dihydro-quinazolin-2-yl) - (2-aryloxy-ethyl) - amines having an activity on the 5 - ht receptor
MX2010002899A (es) Derivados de azaciclilisoquinolinona e isoindolinona como antagonistas de la histamina-3.
ATE520651T1 (de) Substituierte phenylmethylbicyclocarbonsäureamidverbindungen
DE602006006712D1 (de) Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
MX2011008850A (es) Derivados de piperidina como antagonistas del receptor de neuroquinina 3 (nk3).
ATE466854T1 (de) 1h-indol-6-ylpiperazin-1-ylmethanonderivate zur verwendung als h3-rezeptormodulatoren
ATE512142T1 (de) Pyrimidin- und chinazolinderivate als modulatoren der somatostatin-rezeptor aktivität
ATE467632T1 (de) Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors
MX2012001799A (es) Derivados de pirrolidina como antagonistas del receptor de neuroquinona 3 (nk3).
MX2009005242A (es) Derivados de 3-(hetero)arilisoquinolinamida sustituida en posición 5, 6 o 7 y uso terapeutico del mismo.
DE602006014022D1 (de) 5-substituierte indol-2-carbonsäureamidderivate
ATE498622T1 (de) Prolinamidtetrazolderivate als nk3- rezeptorantagonisten
ATE546455T1 (de) Spiropiperidinderivate als nk3-antagonisten
IL184439A0 (en) 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1
ATE549316T1 (de) Piperidinderivate als nk3-rezeptorantagonisten
TW200700390A (en) Metabolites for nk-1 antagonists for emesis
ATE499099T1 (de) Substituierte tetrahydro- chinolinsulfonamidverbindungen, ihre herstellung und ihre verwendung als medikamente
DE602007008947D1 (en) 4,5,6,7-tetrahydrothienoä2,3-cüpyridine als h3-modulatoren
ATE411299T1 (de) Chlorsubstituierte guanidine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2155729

Country of ref document: EP